Related Experiment Videos
Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis
Carmen Espejo1, Milena Penkowa, Irene Sáez-Torres
1Unitat de Neuroimmunologia Cli;nica, Hospital Vall d'Hebron, 08035, Barcelona, Spain.
Experimental Neurology
|November 14, 2002
Summary
Interferon-gamma (IFN-gamma) plays a protective role in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. Mice lacking the IFN-gamma receptor showed increased oxidative stress and cell death, indicating IFN-gamma
Area of Science:
- Neuroimmunology
- Pathology of demyelinating diseases
Background:
- Experimental autoimmune encephalomyelitis (EAE) is a key animal model for multiple sclerosis.
- Oxidative stress and cytokine dysregulation are implicated in EAE neuropathology.
- The specific role of interferon-gamma (IFN-gamma) in EAE pathogenesis remains unclear.
Purpose of the Study:
- To investigate the role of IFN-gamma in the pathogenesis of EAE.
- To determine the impact of IFN-gamma signaling on oxidative stress and apoptosis in EAE.
Main Methods:
- Utilized wild-type and IFN-gamma receptor-knockout (IFN-gamma R(-/-)) mice immunized with myelin oligodendrocyte glycoprotein peptide.
- Assessed oxidative stress markers (inducible NO synthase, nitrotyrosine, malondialdehyde) and antioxidant factors (metallothionein I+II).
- Quantified apoptotic cell death using the TUNEL technique.
Main Results:
- EAE induction led to increased oxidative stress, metallothionein I+II expression, and apoptotic cell death in all mice.
- IFN-gamma R(-/-) mice exhibited significantly higher levels of oxidative stress, metallothionein I+II, and apoptosis compared to wild-type mice.
- These findings suggest a protective role for IFN-gamma in mitigating EAE-associated damage.
Conclusions:
- IFN-gamma appears to have a protective effect against the neuropathology of EAE.
- Disruption of IFN-gamma signaling exacerbates oxidative stress and cell death in this multiple sclerosis model.
- Targeting IFN-gamma pathways could be a potential therapeutic strategy for demyelinating diseases.